Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.10.0.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended
Jul. 31, 2018
Jul. 31, 2017
Revenues:    
Revenue $ 0 $ 0
Operating Expenses:    
Research and development costs 267,794 427,670
Compensation expense 417,190 581,434
Director fees 81,130 96,346
Legal and professional 147,636 195,109
General and administrative 301,613 387,856
Total operating expenses 1,215,363 1,688,415
Loss from operations (1,215,363) (1,688,415)
Net loss $ (1,215,363) $ (1,688,415)
Basic and diluted loss per share $ (0.00) $ (0.00)
Weighted average shares outstanding basic and diluted 1,046,496,430 925,579,393